510(k) device
Dana
Anthrotronix, Inc. · Recorder, Attention Task Performance (LQD, Unclassified) · First FDA decision Oct 15, 2014, newest Oct 15, 2014ADHD
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
21
Naming "Dana"
MAUDE reports
0
Brand "Dana", since 2015
PubMed studies
1,856
Mentioning "Dana"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dana
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- DANA510(k)
K141865 · Decided Oct 15, 2014 · 97 days after receipt
Device type: Recorder, Attention Task Performance (LQD) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Dana", any status and sponsor, newest update first.
- Day and Night Closed-loop in Young People With Type 1 DiabetesPivotal-lookingCompleted
Jaeb Center for Health ResearchAcademic, hospital or other
NCT02925299 · 133 participants · Start May 12, 2017 · Primary completion Aug 27, 2020
Device: FlorenceM (US) and FlorenceX (UK); Insulin pump therapy · For: Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose Metabolism Disorders and 2 more
Sites: Palo Alto, California; Aurora, Colorado; Hartford, Connecticut · 11 sites in all
University of CambridgeAcademic, hospital or other
NCT03784027 · 81 participants · Start May 1, 2019 · Primary completion Feb 22, 2021
Device: CamAPS FX · For: Type 1 Diabetes Mellitus
Sites: Graz, Austria; Innsbruck, Austria; Vienna, Austria · 8 sites in all
University of CambridgeAcademic, hospital or other
NCT04025762 · 38 participants · Start Sep 1, 2019 · Primary completion Aug 20, 2021
Device: Hybrid closed-loop system (CamAPS FX); Sensor augmented pump therapy · For: Type 1 Diabetes Mellitus; Hypoglycemia; Arrythmia
Sites: Cambridge, United Kingdom; Manchester, United Kingdom
18 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Dana", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LQD
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Dana"[tiab]. The summary above synthesizes these.
- Remembering Dana Birksted-Breen.
Tuckett D · Int J Psychoanal · 2024
- [Neuroethics].
Ramiro HM · Rev Med Inst Mex Seguro Soc · 2015Editorial, Historical Article
- Dana Birksted-Breen 12/7/1946-1/6/2024.
Bronstein C · Int J Psychoanal · 2024
- Editorial: Remembering Dana Birksted-Breen.
Grier F · Int J Psychoanal · 2024Editorial, Historical Article
- Dana.
Huggard KM · CMAJ · 2026
- Charles Loomis Dana.
Brust JC · Ann Neurol · 1992Biography, Historical Article
- Depressing questions.
Kaiser J · Science · 1996News
- Thank you to Dr. Dana Turner.
Gelfand A · Headache · 2024Editorial, Historical Article
- Dana on Martin's Bandage.
Dana CL · Chic Med J Exam · 1879
- Editorial: "What would Dana have done?".
Grier F · Int J Psychoanal · 2024Editorial
- Reply to Peterson-Dana and Palanci.
Guinart D, Kane JM · Psychiatr Serv · 2020Letter, Comment
- Charles Loomis Dana: A Vital Presence-a Tribute.
Sachs B · Ann Med Hist · 1936Editorial
Other devices of this type
Also filed under product code LQD.
- Test of Variables of Attention (T.O.V.A.)The Tova Company · 510(k) 2018
- QbCheckQbtech AB · 510(k) 2016
- Qb TestQbtech AB · 510(k) 2014
- QbtesQbtech AB · 510(k) 2012
- QbtestQbtech AB · 510(k) 2004
- Optax SystemOptax Systems, Inc. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.